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Purpose: Pseudoangiomatous stromal hyperplasia (PASH)
of the breast is a rare, benign condition that can be mistaken
as a fibroadenoma on an ultrasound examination or as a low-
grade angiosarcoma on a histological examination. The
objective of this study was to evaluate the ultrasound features
and to present biopsy methods to correctly identify PASH.
Patients and Methods: We retrospectively reviewed the data
of 55 women who were diagnosed with PASH of the breast.
Ultrasound features were evaluated according to the Breast
Imaging Reporting and Data System (BI-RADS; American
College of Radiology). The diagnostic ability of different
biopsy methods such as core needle biopsy, vacuum-assisted
biopsy and excisional biopsy were analyzed with the final
histopathological results of surgical specimens. Results: PASH
presented as a circumscribed solid mass, with hypoechoic
texture with or without heterogeneity, and a parallel orientation.
The features of small, internal cysts or vascular channels and
no calcifications can be used to differentiate the lesions from
fibroadenomas. A core needle biopsy misdiagnosed PASH in
13 cases out of 28 cases and vacuum-assisted biopsy correctly
identified PASH in all 3 cases. Conclusion: Ultrasound
features of PASH should be noted when performing a biopsy.
For inconclusive cases of PASH, an excisional biopsy
followed by an initial core biopsy should be performed.
Key Words: Pseudoangiomatous stromal hyperplasia, breast,
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INTRODUCTION
PASH of the breast was first described by
Vuitch et al.
1 in 1986. PASH presents as a benign
stromal lesion containing complex anastomosing
channels lined by slender spindle cells. In many
cases, PASH is identified during a histological
examination of tissue because of the presence of
other tumors, but it presents as a painless, palpable,
unilateral mass, ranging in size from 1 cm to 15
cm in approximately 40% of cases. Histologically,
PASH can be mistaken for a low-grade angiosar-
coma and phyllodes tumor, but it is a benign
condition. Correct identification of PASH of the
breast has important treatment implications for
patients. To the best of our knowledge, few radio-
logical characteristics differentiate this lesion from
a fibroadenoma, but we were able to identify
some imaging features that are specific to PASH.
There have been several case reports of PASH;
2-4
this study is a review of 55 cases of PASH, based
mainly on ultrasound (US) findings. We present
the results of the use of three biopsy techniques
for making a histological diagnosis-core biopsy
(with the use of a 14-gauge needle), vacuum-
assisted biopsy (with the use of an 11-gauge or
8-gauge needle) and excision biopsy.
PATIENTS AND METHODS
Patients
A retrospective review of the case records of 55
female patients with a final pathological diagnosis
of PASH, diagnosed from March 2000 to March
2006 at Seoul Samsung Hospital or Kangbuk
Samsung Hospital in Korea, was undertaken. Six
of 55 patients were excluded from the study,
because PASH was an incidental finding in
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mastectomy specimens in breast cancer without
associated images. Three patients had no available
ultrasound images. The age range for 49 patients
ultimately enrolled in the study was 15 - 53 years,
with a mean age of 41 years. All patients evaluated
were premenopausal. Twenty-two of the study
patients visited the clinic because of a palpable
breast mass, and 27 patients were identified
through screening breast US procedures.
US examinations
We used an HDI 5000 (Advanced Technology
Laboratories, Bothell, WA, USA), IU22 (Philips
Medical Systems, Bothell, WA, USA) or LOGIQ
700 ultrasound scanner (GE Medical Systems,
Milwaukee, WI, USA) equipped with a 12 - 5-MHz
linear-array transducer. Experienced board-certified
breast radiologists with at least 5 years of ex-
perience in breast US performed or supervised all
sonographic examinations. We performed bilateral
whole breast US including both axillae.
Pathological correlation
Pathologists who specialized in breast diseases
made the initial diagnoses for the 49 patients in
the study. Three diagnostic methods were
employed: a 14-gauge needle core biopsy (28/49),
an 8-guage or 11-guage needle vacuum-assisted
biopsy (Mammotome, SCM 23, Ethicon, Endo-
surgery, Cincinnati, OH, USA) (9/49) depending
on the tumor size and an excision biopsy (12/49).
Indications for the biopsy were BI-RADS category
4a lesions or category 3 lesion with either palpable
lesion or lesions with high risk history or when
follow up US was not feasible. At least 5 speci-
mens with a long diameter of 1 cm were obtained
using a 14-guage needle and specimens from
different areas of the lesion were obtained. For
vacuum-assisted biopsies, specimens were obtained
until the visualized tumor was totally removed
under US guidance. For a nodule less than 2 cm
in diameter an 11-guage needle was used and for
larger nodules, an 8-guage needle was used. The
specimens varied in size and number, and they
were fixed in 10% formalin solution and were
stained with haematoxylin-eosin. A pathologist
reviewed all of the biopsy slides, and immunohis-
tochemical studies were performed with anti-
CD34, factor VIII-related antigen, and avidin-
biotin-peroxidase complex to diagnose PASH.
Radiologists retrospectively analyzed the avail-
able US images of 46 patients. Image analysis was
performed by 2 radiologists who correlated the
final histopathology and US features originally
described according to the Breast Imaging
Reporting and Data System of the American
College of Radiology.
5 We correlated the patholo-
gical results according to the biopsy methods and
the follow-up US findings.
Indication of surgical excision in benign-confirmed
patients
Among 6 patients with benign-confirmed
lesions who underwent further surgical excision,
1 was an image-pathology discordant case where
the final pathology revealed stromal fibrosis with
PASH. For the other 5 cases, palpable lesions
causing pain or discomfort with triple assessment
that showed no evidence of malignancy were
candidates for surgical excision to promptly
resolve the discomfort of patients.
RESULTS
Imaging features
Lesions ranged from 0.7 to 7 cm in size (mean
size = 2.35 cm). Eighteen cases of PASH showed
the presence of a well-circumscribed solid mass,
with hypoechoic texture with or without hetero-
geneity, and parallel orientation (Fig. 1). The pre-
sence of small internal cysts or vascular channels
was noted in 3 cases; these features were not found
in fibroadenomas (Fig. 2). No calcifications were
found, in contrast to findings for fibroadenomas.
BI-RADS categories of 46 masses were category
3 (probably benign) in 30 cases, category 4a (low
suspicion of malignancy) in 15 cases (Fig. 3), and
category 4b (intermediate suspicious of malignancy)
in 1 case (Fig. 4). The nodule that was categorized
as 4b was irregular in shape, not parallel to the
breast axis with a spiculated margin, and was
hypoechoic with posterior shadowing and an
echogenic halo. This case was originally diagnosedUS Feature and Biopsy Methods of PASH in Breast
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as stromal fibrosis by a core biopsy, however the
lesion was identified as PASH after an excisional
biopsy. US findings of each nodule including
shape, margin, internal echogenicities and
posterior acoustic transmission are described in
Table 1. The echogenicity of each lesion was
compared with that of the surrounding normal fat
lobules. One case showed an echogenic halo
instead of an abrupt interface, and 2 lesions
demonstrated internal vascular channels. Two
cases of PASH were seen as a round mass that
was not parallel to the chest wall (Fig. 5). Seven
cases of non-mass forming, but depicted as only
low echoic lesions, were intermingled with the
normal parenchyma (Fig. 6).
Mammograms were available for 5 of 49 patients.
Two patients showed oval, indistinct, high-density
lesions with a background of extremely dense
glandular parenchyme, and 3 patients showed
asymmetrical densities. No characteristic radio-
logical features of PASH were found in the
mammograms.
Pathological findings
PASH represented the initial target lesion in all
but 6 specimens. The 6 cases with different
diagnosis following a core biopsy were diagnosed
as PASH after an additional excisional biopsy or
vacuum-assisted biopsy.
Fig. 1. Transverse sonography of PASH shows an appro-
ximate 5 cm sized well-circumscribed homogeneous
hypoechoic oval mass in a 30-year-old woman who
presented with a palpable mass in the right breast. PASH,
pseudoangiomatous stromal hyperplasia.
Fig. 2. (A) Sonography demonstrates a well-circumscribed
homogeneous hypoechoic mass. (B) Doppler US shows
vascular channels (arrows) in the lesion. In these cases, a
histological examination also identified the presence of
vascular channels. US, ultrasound.
Fig. 3. Fibrocystic change was confirmed after an initial
core needle biopsy, but surgical excision identified PASH
in a 42-year-old premenopausal woman with BI-RADS
category 4a. US shows a 2.8 cm sized heterogeneous echoic
nodule mixed with an ill-defined margin with an irregular
shape. PASH, pseudoangiomatous stromal hyperplasia;
BI-RADS, breast imaging reporting and data system; US,
ultrasound.
A
BFig. 4. Transverse (A) and longitudinal (B) breast US scans. A nodule, characterized as BI-RADS category 4b, was irregular
in shape, not parallel to the breast axis with a spiculated margin, and was hypoechoic with posterior shadowing and
an echogenic halo, which presented as a cancer or radial scar. This case was originally diagnosed after a core biopsy
and was confirmed as stromal fibrosis, but an excisional biopsy identified the lesion as PASH. BI-RADS, breast imaging
reporting and data system; PASH, pseudoangiomatous stromal hyperplasia; US, ultrasound.
Table 1. Sonographic Feature according to BIRADS Description of Pseudoangiomatous Stromal Hyperplasia
US feature according to BI-RADS PASH (n = 46)
Shape Oval 28
Round 2
Irregular 16
Margin Circumscribed 19
Indistinct 14
Angular 4
Microlobulated 8
Spiculated 1
Lesion boundary Abrupt interface 36
Echogenic halo 10
Echo pattern Anechoic 0
hyperechoic 1
Complex 18
Hypoechoic 17
Isoechoic 10
Posterior acoustic features No posterior shadowing 30
Posterior enhancement 13
Posterior shadowing 3
BI-RADS, breast imaging reporting and data system; US, ultrasound; PASH, pseudoangiomatous stromal hyperplasia; Echo,
echogenicity.
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Core biopsy findings
Twenty-eight of 49 patients in our study under-
went a core breast biopsy and 22 patients (78.6%)
were diagnosed with PASH. PASH was not
diagnosed by a core biopsy in 6 patients (21.4%);
the patients were diagnosed with stromal fibrosis
(4/28), fibrocystic changes (1/28) and a fibro-
adenoma (1/28). For these 6 patients, PASH was
identified after an additional excisional biopsy (n=
5) or vacuum-assisted biopsy (n = 1). Among 28
patients who were diagnosed with PASH
following an initial core biopsy, 16 patients
underwent further surgical excision. A fibroa-
denoma was identified in 4 cases, predominant
Table 2. Final Pathology Summary for 20 Patients Who Underwent Further Excision
Initial diagnosis Final pathology (diagnosis after surgical excision)
PASH diagnosed after a core biopsy (n = 12) FA = 4, FCC = 1, FCC with FDH = 1
FCC with FA = 1, Stromal fibrosis = 1
SF, PASH, adenosis = 1
PASH, FDH= 1
PASH+ SF = 1
PASH after a vacuum assisted biopsy = 1
Stromal fibrosis after a core biopsy (n = 4) PASH= 4
Fibroadenoma after a core biopsy (n = 1) PASH, PASH+ SF = 1
PASH after a vacuum assisted biopsy (n = 3) PASH after further excision = 2
Excision revealed FCC with intraductal papilloma = 1
PASH, pseudoangiomatous stromal hyperplasia; FA, fibroadenoma; FCC, fibrocystic change; FDH, focal ductal hyperplasia; SF,
stromal fibrosis.
Fig. 5. Transverse (A) and longitudinal (B) breast US scans. This circumscribed round but not parallel to the chest wall
PASH lesion was initially diagnosed as a fibroadenoma after a core biopsy. PASH, pseudoangiomatous stromal
hyperplasia; US, ultrasound.
Fig. 6. Non-mass-forming PASH. PASH was depicted not
as a mass but as low echoic lesions intermingled with the
normal parenchyma. The initial pathological diagnosis of
this case was fibrocystic change, but the lesion was iden-
tified as PASH after surgical excision. PASH, pseudoan-
giomatous stromal hyperplasia.
A BYoon Jung Choi, et al.
Yonsei Med J Vol. 49, No. 5, 2008
fibrocystic changes in 3 cases and one case of
stromal fibrosis was identified. The final diagnosis
for the other 8 patients was unchanged. Table 2
presents the initial pathology results according to
the different biopsy methods employed and final
pathology results for the patients who underwent
further excision.
Vacuum-assisted biopsy Findings
Nine of 49 patients were diagnosed with PASH
following a vacuum-assisted biopsy. Of 9 patients,
3 patients underwent further excision, which
confirmed the original diagnosis of 2 cases. An
underestimated diagnosis of PASH combined
with atypical lobular hyperplasia with low-grade
carcinoma in situ was found in the third case,
whereas the original diagnosis from an vacuum-
assisted biopsy was PASH with intraductal
papilloma (Table 2). The remaining 6 patients
showed no residual lesion or recurrence on
follow-up US.
Excisional biopsy findings
In all cases, diagnosis included PASH (8/12),
fibroadenoma, usual ductal hyperplasia and
PASH (1/12), intraductal hyperplasia with focal
atypia and PASH (1/12), stromal fibrosis with
PASH (1/12), and fibrocystic changes, papillo-
matosis and PASH (1/12).
Follow-up imaging studies were available for 9
of 46 patients whose US studies were reviewed.
Of 9 patients whose lesions were biopsied under
US guidance, 2 patients had follow-up imaging
that did not demonstrate any change in the lesion
appearance. Follow-up imaging for 7 of 9 patients
who underwent an excisional biopsy and 1 patient
who underwent an vacuum-assisted biopsy with
complete removal of the lesion demonstrated no
evidence of recurrence. Follow-up studies were
not available for the remaining patients.
DISCUSSION
PASH, a benign proliferation of stromal cells
composed of myofibroblasts
1 is associated with
other benign entities, which include proliferative
and nonproliferative fibrocystic changes, fibroa-
denomas, gynecomastia, and sclerosing lobular
hyperplasia.
6 It is found as an incidental finding
in about 23% of breast biopsy specimens.
7
Although these lesions do not occur commonly
and they represent a diagnostic challenge, Piccoli
et al.
8 reported 13 cases of PASH out of 16 cases
of biopsy specimen in developing asymmetric
tissue after mammography, suggesting that PASH
is a rather common histopathological finding in
mammography with a growing asymmetric
density. The pathological diagnosis of PASH may
be difficult unless clinical information and radio-
logical impressions are provided, so that the
pathologic diagnosis can be focused more on
stromal changes.
The etiology of mass-forming PASH is not
known. Vuitch and colleagues
1 and Rosen et al.
9
have suggested that mass-forming PASH represents
an exaggeration of normal physiological events
that histologically resemble breast stromal cells in
the luteal and secretory phases of the menstrual
cycle.
The US appearances of PASH have previously
been described by several investigators,
2,4,8,10 but
with limited number of cases. Polger et al.
10
reported 3 of 4 masses as solid and hypoechoic,
whereas 1 mass was heterogeneous with a small
cystic component. Cohen et al.
2 reported 6 of 7
lesions as solid, hypoechoic masses and 1 case of
a spiculated hypoechoic nodule depicted on
sonography. We identified several common
sonographic characteristics of PASH with a large
number of cases. Our study showed that not all
of the lesions were oval, with the longitudinal axis
of the lesion oriented parallel to the chest wall; 16
lesions showed an irregular shape, and 9 lesions
were not parallel to the chest wall. Although most
of the lesions identified in our study were solid
and hypoechoic in echotexture, some lesions were
heterogeneous in appearance. This heterogeneity
may be due to inclusion of elements other than
fibrous stroma (e.g., fibrocystic changes or adipose
tissue). In 3 cases, the lesions demonstrated post-
erior acoustic shadowing. Sonography demon-
strated the presence of vascular channels in 2
large lesions. In these cases, a histological exami-
nation also revealed the presence of vascular
channels. On histopathology, the nodules that hadUS Feature and Biopsy Methods of PASH in Breast
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peripheral echogenic rims consisted of a central
area of PASH with irregular borders surrounded
by adipose tissue with surrounding heterogenous
parenchyma.
For tissue confirmation, several investigators
have described cytological features of PASH,
suggesting that the findings are non-specific.
11-14
The differential diagnosis includes fibroadenoma
and phyllodes tumor, fibrocytic change and low-
grade sarcoma. Other investigators have reported
false negative cases of PASH diagnosis after a core
needle biopsy.
15 When PASH is the predominant
lesion determined after a needle core biopsy,
correlation of clinical and ultrasound findings is
critical to ensure that the targeted area was
sampled. Our data indicate that an adequate
target is not always obtained after a core biopsy,
because the biopsied tissue sample is small and
has heterogeneous histological composition of the
lesion. In our study, 28 patients underwent a core
biopsy, and 17/28 patients underwent follow-up
excision or a vacuum-assisted biopsy. PASH was
missed in 6 of these cases, and PASH was
diagnosed only in the biopsy specimens in eight
cases and was not observed in the specimens after
further excision. Vacuum-assisted biopsy is not
routinely used to remove PASH, however, a
published report of vacuum-assisted resection of
benign breast tumor
16 presents the method as
feasible and safe without serious complications as
a single step, minimally invasive procedure. Based
on our experience, a vacuum-assisted biopsy was
also feasible and safe to practice, although it was
not routinely applied for complete excision, but as
a biopsy method when a specific and accurate
diagnosis was required. Higher accuracy would
be expected with the use of vacuum-assisted
biopsy than the use of a core biopsy as the
biopsied sample is larger.
The recommended treatment for PASH is wide
local excision.
17 A recently published study showed
that non-surgical management strategies can be
considered for patients who refuse a surgical pro-
cedure and options may be acceptable, especially
when the lesion is small and triple assessment has
been performed to exclude a malignancy.
18 Some
reports document an impressive response to
tamoxifen in a patient presenting with breast
enlargement, pain, and breast masses,
19 however
long term use may not be ideal, considering the
potential side effects. None of the patients in our
study was prescribed tamoxifen as a treatment
drug.
The recurrence rates of PASH after the excision
ranges from 15 to 22%,
1,6,9,10 although we did not
find any recurrence in the patients who underwent
excision. However, complete follow-up evaluation
was not performed for all of the patients,
therefore a low recurrence rate is not conclusive.
A limitation of this study is that it was a
retrospective study of PASH. The value of
vacuum-assisted biopsy for PASH cannot be
substantiated with only 3 cases that were surgi-
cally confirmed. Additional long-term follow-up
studies are required to evaluate the outcome of
vacuum assisted biopsy when further surgical
excision was not undertaken. For patients who
had surgical excision of PASH, longer follow-up
studies are needed to evaluate the rate of
recurrence. For patients who did not undergo
surgical excision, more careful follow-up and
clinical outcome should further be evaluated.
Best biopsy combination for inconclusive cases
of PASH appears to be the combination of a core
biopsy followed by an excisional biopsy.
Radiologists should be informed about the US
features of PASH; the lesions do not always
present as an oval mass with parallel orientation.
The diagnosis of PASH should carefully be
considered by consultation with radiologist,
pathologist and clinician.
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